FDA
44 statements across 19 episodes · 27 bullish · 11 bearish · 10 people on the record · first statement Mar 15, 2020 by David Friedberg · across every show →
Everything said about FDA, oldest first
Mar 15, 2020 positive
Friedberg: Remdesivir should be widely distributed in hospitals without compassionate use restrictions
“Rendesivir should be broadly and widely available right now. People shouldn't have to file for compassionate use to get it. They should be making it, printing it should be in every hospital, and people can decide whether or not they want to take the risk.”
Apr 11, 2020 negative
Sacks: Public health agency responses amount to malpractice and negligence
“But if by health system, we mean the FDA, the CDC the WHO, which is part of the U S system, but we do rely on them to some extent. You've just seen, I think, you know, amazing really malpractice or negligence. If they were a pharma company, I think they'd be s…”
Apr 11, 2020 positive
Jun 13, 2021
Jun 13, 2021 positive
Sacks: FDA should conditionally approve terminal disease drugs as Phase 4 trials
“These people have nothing to lose, and so I would let the drug through, I think, and then watch how it performs over the next couple of years. They could always revoke the approval in two years, you know. In other words, almost consider the usage of the drug o…”
Jan 6, 2023 bullish
Mar 31, 2023 bullish
Apr 14, 2023 bearish
Jul 21, 2023 negative
Ramaswamy: FDA regulation crowds out individual consumer scrutiny of medicines
“I think people would be far more. Scrutinizing of the medicines they took if it didn't come with the crowding out effect of that individual level of self-responsibility and due diligence that the government wasn't doing.”
Sep 16, 2023 negative
Gurley: FDA antigen test chief previously worked at Quidel and Abbott
“Now, he works for the FDA, and he runs the group that oversees which antigen test gets approved. I know this because he would write scathing letters to the ones he rejected that you can also look up online. Now, guess what? You're not going to be surprised. Fi…”
Sep 25, 2023
FDA blocks clinical trials for lifestyle gene therapies like aging or sleep
“The FDA only lets you queue up clinical trials to test drugs that are for diseases, but aging is not a disease state. Wanting to sleep fewer hours is not a disease state. Insomnia is, but wanting to just sleep fewer hours and be fully rested is not a disease s…”
Oct 8, 2024 positive
Oct 8, 2024 positive
Jan 19, 2025 neutral
Cruz: 'Results Act' would mandate FDA reciprocity with other developed nations
“The Results Act says that if any pharmaceutical, any medical device is approved in another major developed country, so approved in Canada or Japan or the EU, That the FDA has 60 days to approve it here, or it's deemed automatically approved by operation.”
Jan 20, 2025 neutral
Jan 15, 2026 positive
Jan 15, 2026 positive
Jan 15, 2026 positive
FDA issues 1,500 drug ad enforcement letters under Makary
“I sent out 1500 enforcement letters, including over a hundred cease and desist letters for ads that were creating a misleading impression, including online pharmacies that are advertising drugs without the same, ah side effects that pharma companies list when …”
Jan 15, 2026 negative
Jan 15, 2026 positive
Jan 15, 2026 positive
Jan 15, 2026 positive
Jan 15, 2026 positive
Jan 15, 2026 positive
Jan 15, 2026 positive
Jan 15, 2026 positive
Jan 15, 2026 positive
Makary: FDA created a plausible mechanism pathway for bespoke gene therapies
“These bespoke therapies, we created essentially a novel pathway for them. Dr. Vinay Prasad described it in the New England Journal of Medicine. It's called the plausible mechanism pathway, and it's basically combining gold standard science with common sense.”
Jan 15, 2026 positive
Jan 15, 2026 negative
Jan 15, 2026 positive
Jan 15, 2026 bullish
FDA hiring 1,050 new scientists to expand accelerated drug approval pathways
“We are actually hiring 1050 new scientists because we have very ambitious goals on our new pathways, accelerated type pathways, and so we're building up capacity to have a whole new line of pathways so that we can deliver faster for the American people.”
Jan 15, 2026 positive
Makary: FDA deregulating health wearables unless claiming medical-grade accuracy
“They're going to be deregulated, so you can give those results of any physiologic parameter, but if you say that it's a quote unquote medical grade blood pressure, then we are going to want to see the data to make sure that it's validated with the gold standar…”
Jan 15, 2026 neutral
Jan 15, 2026 negative
Jan 15, 2026 positive
Jan 15, 2026 positive
FDA reduces biosimilar approval timeline from up to 8 years to 2.5
“We have changed the requirements so that we use the same principles we use for small molecules If you are structurally the same as a small molecule branded drug, we're going to approve you with some other stipulations. And so we are reducing the cost of R&D of…”
Jan 15, 2026 positive
Jan 15, 2026 negative
Makary: FDA halted Biden-era policy allowing CAR-T cell editing in China
“We did find that there was in the Biden administration approval to have the cells of Americans for CAR T therapy shipped to China where the Chinese did the gene editing and then shipped back to the United States. To infuse in Americans. When I found out about …”
Feb 28, 2026 positive
May 1, 2026 bullish
Friedberg: FDA approval for Retatrutide could come as early as 2026
“That's what they're saying. Could happen sooner. I mean, the data's in, the, you know, the FDA will take their time to evaluate it, but I think given the way this is all looking, could happen sooner, could happen sometime later this year.”
Jun 9, 2026 neutral
Jun 13, 2026 negative
Aug 21, 2026 negative
Friedberg: Slow FDA cycles are shifting global biotech investment to China
“And then separately, a lot of biotech has moved offshore from the U S for the same reason that you're pointing out, which is the FDA approval cycle. Is so long and the stages slow people down so much and China's completely revamped their rules for getting to c…”